Literature DB >> 2820566

Causes and management of cervical intraepithelial neoplasia.

R M Richart1.   

Abstract

The evidence for human papillomavirus (HPV) playing a role in the pathogenesis of lower genital neoplasia is reviewed. It is likely that this group of viruses is etiologically important. It is suggested that cervical lesions be diagnosed as flat condyloma if they contain HPV types six or 11 and as cervical intraepithelial neoplasia (CIN) if they are confined to the epithelium and contain HPV Types 16 or 18 or other types associated with neoplasia. Patients with a Papanicolaou (PAP) smear or clinical evidence of HPV infection in the genital tract should be examined colposcopically, invasive cancer should be excluded, and the HPV-induced lesions should be identified and eradicated.

Entities:  

Mesh:

Year:  1987        PMID: 2820566     DOI: 10.1002/1097-0142(19901015)60:8+<1951::aid-cncr2820601505>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Detection of transforming gene regions of human papillomavirus type 16 in cervical dysplasias by the polymerase chain reaction.

Authors:  J Czeglédy; M Evander; L Veres; L Gergely; G Wadell
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Anal cancer in Chinese: human papillomavirus infection and altered expression of p53.

Authors:  Mao-De Lai; Min-Jie Luo; Jian-Er Yao; Pei-Hui Chen
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

3.  Buffered formalin is the superior fixative for the detection of HPV DNA by in situ hybridization analysis.

Authors:  G J Nuovo; R M Richart
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

4.  Human papillomavirus and cervical intraepithelial neoplasia in women who subsequently had invasive cancer.

Authors:  D Caussy; L D Marrett; A J Worth; M McBride; W E Rawls
Journal:  CMAJ       Date:  1990-02-15       Impact factor: 8.262

5.  Detection of human papillomavirus DNA in genital lesions by using a modified commercially available in situ hybridization assay.

Authors:  M P Meyer; C A Markiw; R R Matuscak; A Saker; K McIntyre-Seltman; A J Amortegui
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

6.  Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia.

Authors:  K Odunsi; G Terry; L Ho; J Bell; J Cuzick; T S Ganesan
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

7.  Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

Authors:  Romy van Baars; Heather Griffin; Zhonglin Wu; Yasmina Jay Soneji; Miekel van de Sandt; Rupali Arora; Jacolien van der Marel; Bram Ter Harmsel; Robert Jach; Krzysztof Okon; Hubert Huras; David Jenkins; Wim Quint; John Doorbar
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

8.  A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.

Authors:  M M Holmes; S H Weaver; S T Vermillion
Journal:  Infect Dis Obstet Gynecol       Date:  1999

9.  NF-κB-induced KIAA1199 promotes survival through EGFR signalling.

Authors:  Kateryna Shostak; Xin Zhang; Pascale Hubert; Serkan Ismail Göktuna; Zheshen Jiang; Iva Klevernic; Julien Hildebrand; Patrick Roncarati; Benoit Hennuy; Aurélie Ladang; Joan Somja; André Gothot; Pierre Close; Philippe Delvenne; Alain Chariot
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

10.  Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.

Authors:  F V Cromme; C J Meijer; P J Snijders; A Uyterlinde; P Kenemans; T Helmerhorst; P L Stern; A J van den Brule; J M Walboomers
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.